We are live on ! Find out more
TSVT

2seventy bio

Delisted

TSVT was delisted on the 13th of May, 2025.

146 hedge funds and large institutions have $508M invested in 2seventy bio in 2023 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 55 increasing their positions, 21 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

162% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 21

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

80% more call options, than puts

Call options by funds: $656K | Put options by funds: $364K

60% more capital invested

Capital invested by funds: $317M → $508M (+$191M)

20% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 25

4% more funds holding

Funds holding: 141146 (+5)

Holders
146
Holders Change
+5
Holders Change %
+3.55%
% of All Funds
2.33%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
30
Increased
55
Reduced
21
Closed
25
Calls
$656K
Puts
$364K
Net Calls
+$292K
Net Calls Change
-$6K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
26
Bank of America
North Carolina
$4.08M +$2.84M +248,244 +164%
Barclays
27
Barclays
United Kingdom
$4.02M +$3.63M +317,124 +412%
DTC
28
Deep Track Capital
Connecticut
$3.57M +$4M +350,000 New
Northern Trust
29
Northern Trust
Illinois
$3.57M -$86.6K -7,571 -2%
Charles Schwab
30
Charles Schwab
California
$3.26M -$18.1K -1,586 -0.5%
Fidelity Investments
31
Fidelity Investments
Massachusetts
$3.12M -$3.28M -286,635 -48%
AA
32
AlphaCentric Advisors
Puerto Rico
$3.09M +$1.4M +122,500 +68%
Citigroup
33
Citigroup
New York
$2.68M +$2.27M +198,403 +307%
TCM
34
Tang Capital Management
California
$2.55M
CCP
35
Clough Capital Partners
Massachusetts
$2.54M +$2.84M +248,610 New
Rafferty Asset Management
36
Rafferty Asset Management
New York
$2.26M +$1.03M +90,390 +69%
Point72 Asset Management
37
Point72 Asset Management
Connecticut
$2.16M -$805K -70,371 -25%
UBS Group
38
UBS Group
Switzerland
$1.95M +$1.12M +97,928 +105%
SVCM
39
Saturn V Capital Management
Texas
$1.76M -$5.86M -512,808 -75%
Bank of Montreal
40
Bank of Montreal
Ontario, Canada
$1.74M +$1.85M +162,148 New
LPC
41
Lion Point Capital
New York
$1.73M +$1.94M +170,000 New
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$1.72M +$1.69M +147,935 +729%
BL
43
Bleichroeder LP
New York
$1.69M +$1.89M +165,407 New
WAM
44
Weiss Asset Management
Massachusetts
$1.65M
Mirae Asset Global Investments
45
Mirae Asset Global Investments
South Korea
$1.61M +$110K +9,609 +7%
Norges Bank
46
Norges Bank
Norway
$1.59M +$1.78M +156,100 New
Bank of New York Mellon
47
Bank of New York Mellon
New York
$1.43M +$67.2K +5,877 +4%
Jacobs Levy Equity Management
48
Jacobs Levy Equity Management
New Jersey
$1.19M +$12.2K +1,065 +0.9%
Swiss National Bank
49
Swiss National Bank
Switzerland
$966K +$90.3K +7,900 +9%
JCIA
50
Jackson Creek Investment Advisors
Colorado
$945K +$1.06M +92,623 New

TSVT Hedge Fund Activity: Q1 2023 in Review

146 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q1 2023, worth a combined $508M — up 60% from $317M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new TSVT positions and 25 closed out — a net gain of 5 holders — while 55 added to existing stakes and 21 trimmed.

The largest buyer was Kynam Capital Management, opening a new position worth an estimated $42.7M. The largest seller was Madison Avenue Partners, exiting entirely with an estimated $11.2M sold.

  • 146 institutional investors held 2seventy bio (TSVT) as of Q1 2023, up from 141 in Q4 2022.
  • Funds reported $508M of 2seventy bio stock for Q1 2023, up 60% quarter-over-quarter.
  • 30 funds opened new 2seventy bio positions in Q1 2023 and 25 closed out, a net change of +5 holders.
  • The largest 2seventy bio buyer in Q1 2023 was Kynam Capital Management, an estimated $42.7M added.
  • The largest 2seventy bio seller in Q1 2023 was Madison Avenue Partners, an estimated $11.2M sold.

Based on aggregated 13F filings for Q1 2023.